Report of the Meeting of the WHO Global Advisory Committee on Vaccine Safety (GACVS), 8–9 June 2021

Overview

The Global Advisory Committee on Vaccine Safety (GACVS), an independent expert clinical and scientific advisory body, provides WHO with scientifically rigorous advice on vaccine safety issues of potential global importance; provides scientific safety recommendations for policy-making by WHO, the WHO Strategic Advisory Group of Experts (SAGE) on immunization, national governments and international organizations; recommends the creation of ad hoc task forces for methodological and empirical research into potential adverse events and prioritizes aspects of vaccine safety to be monitored during their use.

The 44th GACVS meeting on 8–9 June 2021, held online, addressed a number of pharmacovigilance issues, including the following:

- GACVS COVID-19 Sub-committee

- COVID-19 vaccine-related events early warning system

- Safety profile of nOPV2 vaccine